2101 - 2150 of 8571 Results
Title
Year
- Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications2011RESTRICTEDTitle: Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applicationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 8Start Page: 1386End Page: 1397Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23737Best OA location URL: https://europepmc.org/articles/pmc3150637?pdf=renderCitation Count: 36
-
RESTRICTEDTitle: Biochemical premotor biomarkers for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 5Start Page: 644End Page: 650Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.24956Best OA location URL: https://europepmc.org/articles/pmc3428741?pdf=renderCitation Count: 36
-
RESTRICTEDTitle: The neuropathology of genetic Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 7Start Page: 831End Page: 842Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.24962Best OA location URL: https://europepmc.org/articles/pmc3383342?pdf=renderCitation Count: 254
-
RESTRICTEDTitle: Dopamine overdose hypothesis: Evidence and clinical implicationsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 1920End Page: 1929Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25687Best OA location URL: https://europepmc.org/articles/pmc3859825?pdf=renderCitation Count: 135
- Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?2013RESTRICTEDTitle: Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?Journal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 1915End Page: 1919Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25735Best OA location URL: https://europepmc.org/articles/pmc3859686?pdf=renderCitation Count: 29
-
RESTRICTEDTitle: Lysosomal impairment in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 6Start Page: 725End Page: 732Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25462Best OA location URL: https://europepmc.org/articles/pmc5131721?pdf=renderCitation Count: 267
- Management of impulse control disorders in Parkinson's disease: Controversies and future approaches2015RESTRICTEDTitle: Management of impulse control disorders in Parkinson's disease: Controversies and future approachesJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 2Start Page: 150End Page: 159Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26099Best OA location URL: https://europepmc.org/articles/pmc5077247?pdf=renderCitation Count: 92
- Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients2015RESTRICTEDTitle: Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 12Start Page: 1648End Page: 1656Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26290Best OA location URL: https://europepmc.org/articles/pmc4609229?pdf=renderCitation Count: 67
-
RESTRICTEDTitle: Technology in Parkinson's disease: Challenges and opportunitiesJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 9Start Page: 1272End Page: 1282Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26642Best OA location URL: http://minerva-access.unimelb.edu.au/bitstreams/9b88ef9a-46cf-56a6-adcc-40327184fd3c/downloadCitation Count: 477
- Biomarker‐driven phenotyping in Parkinson's disease: A translational missing link in disease‐modifying clinical trials2017RESTRICTEDTitle: Biomarker‐driven phenotyping in Parkinson's disease: A translational missing link in disease‐modifying clinical trialsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 3Start Page: 319End Page: 324Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26913Best OA location URL: https://ri.conicet.gov.ar/bitstream/11336/40514/5/CONICET_Digital_Nro.82df6a72-6ca0-4e97-82ab-71e013c4c8bf_s.pdfCitation Count: 148
-
RESTRICTEDTitle: Pathological Influences on Clinical Heterogeneity in Lewy Body DiseasesJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 1Start Page: 5End Page: 19Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27867Best OA location URL: https://europepmc.org/articles/pmc7233798?pdf=renderCitation Count: 61
-
RESTRICTEDTitle: Genome‐Wide Association Studies of Cognitive and Motor Progression in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 2Start Page: 424End Page: 433Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28342Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28342Citation Count: 115
-
RESTRICTEDTitle: PD biomarkers—use of α-synuclein reaches new levelsJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 6Start Page: 308End Page: 309Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrneurol.2011.66Best OA location URL: https://europepmc.org/articles/pmc4043344?pdf=renderCitation Count: 1
-
RESTRICTEDTitle: Neural cell state shifts and fate loss in ageing and age-related diseasesJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 19Issue #: 7Start Page: 434End Page: 443Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41582-023-00815-0Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478103Citation Count: 5
-
RESTRICTEDTitle: Roles for the adaptive immune system in Parkinson’s and Alzheimer’s diseasesJournal Name: Current Opinion in ImmunologyPublisher: Elsevier BVVol: 59Issue #:Start Page: 115End Page: 120Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.coi.2019.07.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774843Citation Count: 41
-
RESTRICTEDTitle: AAV viral vector delivery to the brain by shape-conforming MR-guided infusionsJournal Name: Journal of Controlled ReleasePublisher: Elsevier BVVol: 240Issue #:Start Page: 434End Page: 442Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jconrel.2016.02.034Citation Count: 36
- Effectiveness of Physiotherapy on Freezing of Gait in Parkinson's Disease: A Systematic Review and Meta‐Analyses2019RESTRICTEDTitle: Effectiveness of Physiotherapy on Freezing of Gait in Parkinson's Disease: A Systematic Review and Meta‐AnalysesJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 4Start Page: 523End Page: 536Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27936Citation Count: 54
- The Role of the Cerebellum in Degenerative Ataxias and Essential Tremor: Insights From Noninvasive Modulation of Cerebellar Activity2019RESTRICTEDTitle: The Role of the Cerebellum in Degenerative Ataxias and Essential Tremor: Insights From Noninvasive Modulation of Cerebellar ActivityJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 2Start Page: 215End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27919Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27919Citation Count: 47
-
RESTRICTEDTitle: Gait and postural disorders in parkinsonism: a clinical approachJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 267Issue #: 11Start Page: 3169End Page: 3176Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-019-09382-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-019-09382-1.pdfCitation Count: 32
-
RESTRICTEDTitle: Protective effects of fisetin and other berry flavonoids in Parkinson's diseaseJournal Name: Food & FunctionPublisher: Royal Society of Chemistry (RSC)Vol: 8Issue #: 9Start Page: 3033End Page: 3042Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1039/c7fo00809kCitation Count: 59
-
RESTRICTEDTitle: The D3 dopamine receptor: From structural interactions to functionJournal Name: European NeuropsychopharmacologyPublisher: Elsevier BVVol: 25Issue #: 9Start Page: 1462End Page: 1469Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.euroneuro.2014.11.021Citation Count: 38
- Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review2019RESTRICTEDTitle: Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic ReviewJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 2Start Page: 129End Page: 139Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12874Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12874Citation Count: 27
- Protein disulfide isomerases in neurodegeneration: From disease mechanisms to biomedical applications2012RESTRICTEDTitle: Protein disulfide isomerases in neurodegeneration: From disease mechanisms to biomedical applicationsJournal Name: FEBS LettersPublisher: WileyVol: 586Issue #: 18Start Page: 2826End Page: 2834Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.febslet.2012.07.023Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.febslet.2012.07.023Citation Count: 85
-
RESTRICTEDTitle: The role of natural killer cells in Parkinson’s diseaseJournal Name: Experimental & Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 52Issue #: 9Start Page: 1517End Page: 1525Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s12276-020-00505-7Best OA location URL: https://www.nature.com/articles/s12276-020-00505-7.pdfCitation Count: 50
- Genetic, Structural, and Molecular Insights into the Function of Ras of Complex Proteins Domains2014RESTRICTEDTitle: Genetic, Structural, and Molecular Insights into the Function of Ras of Complex Proteins DomainsJournal Name: Chemistry & BiologyPublisher: Elsevier BVVol: 21Issue #: 7Start Page: 809End Page: 818Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.chembiol.2014.05.010Best OA location URL: https://doi.org/10.1016/j.chembiol.2014.05.010Citation Count: 19
-
RESTRICTEDTitle: ER Dysfunction and Protein Folding Stress in ALSJournal Name: International Journal of Cell BiologyPublisher: Hindawi LimitedVol: 2013Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2013/674751Best OA location URL: https://downloads.hindawi.com/journals/ijcb/2013/674751.pdfCitation Count: 91
-
RESTRICTEDTitle: Environmental Exposures and Parkinson’s DiseaseJournal Name: International Journal of Environmental Research and Public HealthPublisher: MDPI AGVol: 13Issue #: 9Start Page: 881End Page: 881Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijerph13090881Best OA location URL: https://www.mdpi.com/1660-4601/13/9/881/pdf?version=1472899297Citation Count: 164
- A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism2016RESTRICTEDTitle: A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonismJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 43Issue #: 12Start Page: 2244End Page: 2254Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00259-016-3464-8Best OA location URL: https://europepmc.org/articles/pmc5047923?pdf=renderCitation Count: 34
-
RESTRICTEDTitle: Young-onset Parkinson's disease: Its unique features and their impact on quality of lifeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 39End Page: 48Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.06.001Citation Count: 76
-
RESTRICTEDTitle: Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-SynucleinopathiesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 11Start Page: 6216End Page: 6216Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms23116216Best OA location URL: https://www.mdpi.com/1422-0067/23/11/6216/pdf?version=1654589185Citation Count: 28
- Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders2016RESTRICTEDTitle: Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disordersJournal Name: Journal of NeurochemistryPublisher: WileyVol: 139Issue #: S1Start Page: 290End Page: 317Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.13390Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13390Citation Count: 58
-
RESTRICTEDTitle: Pathogenic variants in the Longitudinal Early‐onset Alzheimer's Disease Study cohortJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: S9Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.13482Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13482Citation Count: 0
-
RESTRICTEDTitle: Artificial intelligence for neurodegenerative experimental modelsJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 12Start Page: 5970End Page: 5987Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.13479Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13479Citation Count: 3
-
RESTRICTEDTitle: Recent advances in CSF biomarkers for Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 18Issue #:Start Page: S49End Page: S51Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1353-8020(11)70017-7Citation Count: 26
- Optimizing intracellular antibodies (intrabodies/nanobodies) to treat neurodegenerative disorders2020RESTRICTEDTitle: Optimizing intracellular antibodies (intrabodies/nanobodies) to treat neurodegenerative disordersJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 134Issue #:Start Page: 104619End Page: 104619Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104619Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104619Citation Count: 57
-
RESTRICTEDTitle: Association of Rare Variants in ARSA with Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 10Start Page: 1806End Page: 1812Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29521Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29521Citation Count: 3
-
RESTRICTEDTitle: Pick’s Disease, Seeding an Answer to the Clinical Diagnosis ConundrumJournal Name: BiomedicinesPublisher: MDPI AGVol: 11Issue #: 6Start Page: 1646End Page: 1646Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines11061646Best OA location URL: https://www.mdpi.com/2227-9059/11/6/1646/pdf?version=1686036098Citation Count: 3
-
RESTRICTEDTitle: Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 137End Page: 147Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.10.001Citation Count: 50
-
RESTRICTEDTitle: Current disease modifying approaches to treat Parkinson’s diseaseJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 73Issue #: 7Start Page: 1365End Page: 1379Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00018-015-2101-1Citation Count: 88
-
RESTRICTEDTitle: Injury to the nervous system: A look into the ERJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 617End Page: 625Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2016.04.053Citation Count: 24
-
RESTRICTEDTitle: Inflammation is genetically implicated in Parkinson’s diseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 302Issue #:Start Page: 89End Page: 102Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.10.028Citation Count: 190
-
RESTRICTEDTitle: Antibodies and protein misfolding: From structural research tools to therapeutic strategiesJournal Name: Biochimica et Biophysica Acta (BBA) - Proteins and ProteomicsPublisher: Elsevier BVVol: 1844Issue #: 11Start Page: 1907End Page: 1919Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.bbapap.2014.08.016Best OA location URL: https://doi.org/10.1016/j.bbapap.2014.08.016Citation Count: 58
-
RESTRICTEDTitle: Return of D4 Dopamine Receptor Antagonists in Drug DiscoveryJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 60Issue #: 17Start Page: 7233End Page: 7243Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.7b00151Citation Count: 41
- Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease2021RESTRICTEDTitle: Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s diseaseJournal Name: Stem Cell Research & TherapyPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13287-021-02326-5Best OA location URL: https://stemcellres.biomedcentral.com/track/pdf/10.1186/s13287-021-02326-5Citation Count: 9
-
RESTRICTEDTitle: Contribution of GTPase activity toLRRK2-associated Parkinson diseaseJournal Name: Small GTPasesPublisher: Informa UK LimitedVol: 4Issue #: 3Start Page: 164End Page: 170Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.4161/sgtp.25130Best OA location URL: https://www.tandfonline.com/doi/pdf/10.4161/sgtp.25130?needAccess=trueCitation Count: 49
-
RESTRICTEDTitle: The Phenomenology of Parkinson's DiseaseJournal Name: Seminars in NeurologyPublisher: Georg Thieme Verlag KGVol: 37Issue #: 02Start Page: 109End Page: 117Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/s-0037-1601869Best OA location URL: https://europepmc.org/articles/pmc5961724?pdf=renderCitation Count: 32
-
RESTRICTEDTitle: Motor Complications of Dopaminergic Medications in Parkinson's DiseaseJournal Name: Seminars in NeurologyPublisher: Georg Thieme Verlag KGVol: 37Issue #: 02Start Page: 147End Page: 157Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/s-0037-1602423Best OA location URL: https://europepmc.org/articles/pmc5990008?pdf=renderCitation Count: 58
-
RESTRICTEDTitle: Microglia: Friend and foe in tauopathyJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 216Issue #:Start Page: 102306End Page: 102306Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pneurobio.2022.102306Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378545Citation Count: 15
-
RESTRICTEDTitle: Surgical Treatment of Parkinson DiseaseJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 31Issue #: 3Start Page: 799End Page: 808Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2013.03.007Best OA location URL: https://europepmc.org/articles/pmc3728709?pdf=renderCitation Count: 36
-
RESTRICTEDTitle: Genetic Testing for Parkinson DiseaseJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 1Start Page: 69End Page: 77Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000831Best OA location URL: https://cp.neurology.org/content/neurclinpract/11/1/69.full.pdfCitation Count: 23